Company description

Cerus Corporation, trading under the ticker symbol CERS, is a biomedical technology company that specializes in developing and commercializing innovative products to improve the safety of blood transfusions. With a strong focus on preventing the spread of infectious diseases through blood transfusion, the company has developed a unique technology, known as Intercept, which works by inactivating viruses, bacteria, and other pathogens that may be present in donated blood. In addition to this, Cerus also offers a portfolio of information services and expertise to healthcare providers to help them make informed decisions about the safety of blood products. The company's products have been approved for use in over 30 countries worldwide, and it continues to expand its global reach through strategic partnerships and collaborations. With a commitment to continuously improving the standard of care in blood transfusion, Cerus is well positioned to experience significant growth and success in the future.